Healthcare Technology Report January 27, 2025
Outset Medical has announced a major $169 million private placement to advance its groundbreaking work in dialysis care. The funding, led by top institutional investors including T. Rowe Price and Perceptive Advisors, will support the company’s goal of reducing the cost and complexity of dialysis treatments. The deal includes the sale of Series A Non-Voting Convertible Preferred Stock, which, upon shareholder approval, will convert to common stock, bolstering Outset’s resources for continued product innovation and growth. This new capital is expected to help Outset achieve cash flow breakeven, ensuring the company...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices